Product image of Vyloy (Zolbetuximab) supplied by GNH India

Vyloy

Active Ingredient:
Zolbetuximab
Origin:
EU

Vyloy (Zolbetuximab)

Vyloy (zolbetuximab) is an intravenous therapy for certain gastrointestinal cancers. This overview covers its role in treatment plans and general handling notes. Suitable for patients and caregivers seeking foundational information.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyloy (zolbetuximab) is used in combination with other medications to treat specific types of advanced gastric or gastroesophageal junction cancers. It targets cancer cells expressing CLDN18.2, a protein found in some tumors. Patients often explore this option when standard therapies are no longer effective or suitable. Always consult a healthcare provider to determine if Vyloy is appropriate for your condition.

Side Effects

  • Vyloy works by attaching to cancer cells that express CLDN18.2, helping the immune system recognize and attack these cells. Infusions are administered in a clinical setting, allowing healthcare professionals to monitor for reactions. Common effects may include fatigue, nausea, or infusion-related symptoms, which vary by individual.

Precautions & Warnings

  • Vyloy is given under medical supervision in a healthcare facility. Patients should disclose their full medical history, including allergies or prior treatments, to avoid complications. Dehydration or electrolyte imbalances may occur, so adequate hydration is important. Regular monitoring helps manage potential side effects during therapy.

Avoid Interactions

  • Vyloy may interact with medications that affect liver enzymes or immune responses. Inform your doctor about all prescriptions, over-the-counter drugs, and supplements. Alcohol or certain foods might influence tolerability, though specific restrictions depend on individual health. Always follow healthcare provider guidance to minimize interaction risks.

Frequently Asked Questions

Vyloy is used to treat advanced gastric or gastroesophageal junction cancers that express CLDN18.2.

Vyloy is given as an intravenous infusion in a clinical setting under medical supervision.

Common effects may include fatigue, nausea, or symptoms related to the infusion process.

Always consult your healthcare provider before combining Vyloy with other drugs or supplements.

Availability depends on regional regulations and prescription requirements; consult a licensed pharmacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zolbetuximab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT